Enzymes

Enzyme demand in the United States is forecast to increase 3.0 percent annually to $2.2 billion in 2019. Changes in the medical and pharmaceutical industries will result in strong gains in enzymes used in the research and biotechnology, in vitro diagnostics, and biocatalyst markets. Polymerases and nucleases will see the fastest gains among the main enzyme types.This study analyzes the $1.9 billion US enzyme industry. It presents historical demand data (2004, 2009 and 2014) and forecasts (2019 and 2024) by market (e.g., biofuel, food and beverage processing, research and biotechnology, cleaning products, diagnostics, animal feed) and product (e.g., carbohydrases, proteases, polymerases, nucleases, lipases).The study also considers market environment factors, details industry structure, evaluates company market share and profiles 20 industry players, including Novozymes, DuPont, and Roche.